Literature DB >> 8103662

Evidence for an increased catecholamine synthesis in rat adrenal glands following stimulation of peripheral dopamine receptors.

M Kujacic1, A Carlsson.   

Abstract

In studies on peripheral dopamine (DA) turnover in our department evidence has accumulated that changes in adrenal DA levels induced by varying degrees of neurogenic stimulation roughly reflect changes in the catecholamine (CA) synthesis rate. The question arises if changes in DA levels in rat adrenals induced by different DA D-2 receptor agonists and previously reported from our laboratory, also indicate changes in CA synthesis. After various periods of drug administration rats were killed by decapitation and tissue CA levels in adrenals and forebrain were determined by HPLC-EC. The potent inhibitor of DA-beta-hydroxylase FLA 63 (40 mg/kg i.p.) increased adrenal DA by 186% after 1 h and by 423% after 3 h. The DA D-2 agonist quinpirole (0.2 mg/kg s.c., 30 min) itself increased adrenal DA by 55-60% compared to control. In FLA 63 pretreated rats quinpirole increased adrenal DA levels by further 127% (FLA 63-1 h), resp. 122% (FLA 63-3 h) than did FLA 63 itself. The DA D-2 receptor antagonist domperidone (3 mg/kg s.c., 150 min) blocked the quinpirole effect both in saline and FLA 63 (3 h) pretreated rats. Adrenal DOPAC was changed in similar manner as adrenal DA in FLA 63 pretreated rats. No significant changes either in adrenal NA or A were observed after FLA 63 pretreatment. Under the present experimental conditions adrenal DA may thus mainly be looked upon as an intermediate in the synthesis of NA and A, and the elevation of DA induced by DA D-2 receptor stimulation as a consequence of increased catecholamine synthesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8103662     DOI: 10.1007/bf01244867

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  11 in total

1.  Comparison of gene expression of the dopamine D-2 receptor and DARPP-32 in rat brain, pituitary and adrenal gland.

Authors:  M Schalling; A Dagerlind; M Goldstein; M Ehrlich; P Greengard; T Hökfelt
Journal:  Eur J Pharmacol       Date:  1990-04-25       Impact factor: 4.432

2.  Dopamine D2 receptor binding in adrenal medulla: characterization using [3H]spiperone.

Authors:  M Quik; L Bergeron; H Mount; J Philie
Journal:  Biochem Pharmacol       Date:  1987-11-01       Impact factor: 5.858

3.  On the significance of central noradrenaline for motor activity: experiments with a new dopamine beta-hydroxylase inhibitor.

Authors:  T H Svensson; B Waldeck
Journal:  Eur J Pharmacol       Date:  1969-09       Impact factor: 4.432

4.  Studies on central and peripheral noradrenaline neurons using a new dopamine-(beta)-hydroxylase inhibitor.

Authors:  H Corrodi; K Fuxe; B Hamberger; A Ljungdahl
Journal:  Eur J Pharmacol       Date:  1970-10       Impact factor: 4.432

5.  Dopamine receptors, controlling dopamine levels in rat adrenal glands-comparison with central dopaminergic autoreceptors.

Authors:  M Kujacic; K Svensson; L Löfberg; A Carlsson
Journal:  J Neural Transm Gen Sect       Date:  1991

6.  The adrenal dopamine as an indicator of adrenomedullary hormone biosynthesis.

Authors:  S R Snider; A Carlsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

7.  Studies on the neurogenic short-term control of adrenomedullary hormone synthesis.

Authors:  A Carlsson; M Lindqvist
Journal:  J Neural Transm       Date:  1974       Impact factor: 3.575

8.  D2 dopamine receptors modulate calcium channel currents and catecholamine secretion in bovine adrenal chromaffin cells.

Authors:  L Bigornia; C N Allen; C R Jan; R A Lyon; M Titeler; A S Schneider
Journal:  J Pharmacol Exp Ther       Date:  1990-02       Impact factor: 4.030

9.  D2 dopamine receptors on bovine chromaffin cell membranes: identification and characterization by [3H]N-methylspiperone binding.

Authors:  R A Lyon; M Titeler; L Bigornia; A S Schneider
Journal:  J Neurochem       Date:  1987-02       Impact factor: 5.372

10.  Characterization of a dopaminergic receptor that modulates adrenomedullary catecholamine release.

Authors:  M C González; A R Artalejo; C Montiel; P P Hervás; A G García
Journal:  J Neurochem       Date:  1986-08       Impact factor: 5.372

View more
  4 in total

1.  Striatal and urinary DOPAC/DA ratio may indicate a long-lasting DA release enhancement by MPP+ and MPTP.

Authors:  S P Bagchi
Journal:  Neurochem Res       Date:  1998-02       Impact factor: 3.996

2.  I. c. v. dopamine fails to alter adrenomedullary function in rats.

Authors:  M Kujacic; A Carlsson
Journal:  J Neural Transm Gen Sect       Date:  1994

3.  Roles of dopaminergic d(1) and d(2) receptors in catecholamine release from the rat adrenal medulla.

Authors:  Young Joo Baek; Yoo Seong Seo; Dong Yoon Lim
Journal:  Korean J Physiol Pharmacol       Date:  2008-02-28       Impact factor: 2.016

4.  Effects of MPP+ on catecholamine levels in adrenal glands and heart of rats.

Authors:  M Kujacic; A Carlsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-09       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.